Wang et al. [47] further demonstrated that the enforced expression of TWIST1 in KG1a (an AML cell line) increased the sensitivity to the chemotherapy drug cytarabine, but there was no modification observed in the daunorubicin response. Here, TWIST1 is linked to acute myeloid leukemia.